Evidence of CD1d Pathway of Lipid Antigen Presentation in Mouse Primary Lung Epithelial Cells and Its Up-regulation Upon Mycobacterium Bovis BCG Infection

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2019 Jan 1

PMID 30596774

Citations 10

Authors

Zaigham Abbas Rizvi

Niti Puri

Rajiv K Saxena

Affiliations

Soon will be listed here.

Abstract

Presentation of a prototype lipid antigen α-Galactosylceramide (αGC) was examined on primary epithelial cells derived from mouse lungs and on bronchoalveolar lavage (BAL) cells that essentially comprise alveolar macrophages. Presence of CD1d molecules coupled to αGC was demonstrated on both types of cells pre-treated with αGC, suggesting that both cell types are equipped to present lipid antigens. Internalization of Mycobacterium bovis Bacillus Calmette-Guérin (BCG: a prototype pathogen), a pre-requisite to the processing and presentation of protein as well as lipid antigens, was clearly demonstrated in primary lung epithelial (PLE) cells as well as BAL cells. Both PLE and BAL cells expressed CD1d molecule and a significant up-regulation of its expression occurred upon infection of these cells with BCG. Besides CD1d, the expression of other important molecules that participate in lipid antigen presentation pathway (i.e. microsomal triglyceride transfer protein (MTTP), scavenger receptor B1 (SR-B1) and Saposin) was also significantly upregulated in PLE and BAL cells upon BCG infection. In situ up-regulation of CD1d expression on lung epithelial cells was also demonstrated in the lungs of mice exposed intra-tracheally to BCG. Taken together these results suggest that lung epithelial cells may have the ability to present lipid antigens and this pathway seems to get significantly upregulated in response to BCG infection.

Citing Articles

Zinc dampens antitumor immunity by promoting Foxp3 regulatory T cells.

Narayan S, Dalal R, Rizvi Z, Awasthi A Front Immunol. 2024; 15:1389387.

PMID: 39247196 PMC: 11377231. DOI: 10.3389/fimmu.2024.1389387.

Evaluation of Ayush-64 (a Polyherbal Formulation) and Its Ingredients in the Syrian Hamster Model for SARS-CoV-2 Infection Reveals the Preventative Potential of .

Rizvi Z, Madan U, Tripathy M, Goswami S, Mani S, Awasthi A Pharmaceuticals (Basel). 2023; 16(9).

PMID: 37765142 PMC: 10534577. DOI: 10.3390/ph16091333.

Omicron sub-lineage BA.5 infection results in attenuated pathology in hACE2 transgenic mice.

Rizvi Z, Dandotiya J, Sadhu S, Khatri R, Singh J, Singh V Commun Biol. 2023; 6(1):935.

PMID: 37704701 PMC: 10499788. DOI: 10.1038/s42003-023-05263-6.

CD1-mediated immune responses in mucosal tissues: molecular mechanisms underlying lipid antigen presentation system.

Kim S, Cho S, Kim J Exp Mol Med. 2023; 55(9):1858-1871.

PMID: 37696897 PMC: 10545705. DOI: 10.1038/s12276-023-01053-6.

Pharmacological potential of (L.) Dunal and (Willd.) Miers on the experimental models of COVID-19, T cell differentiation, and neutrophil functions.

Rizvi Z, Babele P, Madan U, Sadhu S, Tripathy M, Goswami S Front Immunol. 2023; 14:1138215.

PMID: 36960064 PMC: 10028191. DOI: 10.3389/fimmu.2023.1138215.

References

Zeissig S, Peuker K, Iyer S, Gensollen T, Dougan S, Olszak T . CD1d-Restricted pathways in hepatocytes control local natural killer T cell homeostasis and hepatic inflammation. Proc Natl Acad Sci U S A. 2017; 114(39):10449-10454. PMC: 5625893. DOI: 10.1073/pnas.1701428114. View

Yu K, Im J, Illarionov P, Ndonye R, Howell A, Besra G . Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand alpha-galactosylceramide bound to mouse CD1d. J Immunol Methods. 2007; 323(1):11-23. PMC: 1939826. DOI: 10.1016/j.jim.2007.03.006. View

Bricard G, Porcelli S . Antigen presentation by CD1 molecules and the generation of lipid-specific T cell immunity. Cell Mol Life Sci. 2007; 64(14):1824-40. PMC: 11136151. DOI: 10.1007/s00018-007-7007-0. View

Crapo J, Barry B, Gehr P, Bachofen M, Weibel E . Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis. 1982; 126(2):332-7. DOI: 10.1164/arrd.1982.126.2.332. View

Grubor-Bauk B, Simmons A, Mayrhofer G, Speck P . Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR. J Immunol. 2003; 170(3):1430-4. DOI: 10.4049/jimmunol.170.3.1430. View

Fischer K, Scotet E, Niemeyer M, Koebernick H, Zerrahn J, Maillet S . Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci U S A. 2004; 101(29):10685-90. PMC: 489995. DOI: 10.1073/pnas.0403787101. View

Sugita M, Cernadas M, Brenner M . New insights into pathways for CD1-mediated antigen presentation. Curr Opin Immunol. 2004; 16(1):90-5. DOI: 10.1016/j.coi.2003.11.014. View

Skold M, Behar S . Role of CD1d-restricted NKT cells in microbial immunity. Infect Immun. 2003; 71(10):5447-55. PMC: 201095. DOI: 10.1128/IAI.71.10.5447-5455.2003. View

Behar S, Dascher C, Grusby M, Wang C, Brenner M . Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med. 1999; 189(12):1973-80. PMC: 2192974. DOI: 10.1084/jem.189.12.1973. View

10.

Rizvi Z, Puri N, Saxena R . Lipid antigen presentation through CD1d pathway in mouse lung epithelial cells, macrophages and dendritic cells and its suppression by poly-dispersed single-walled carbon nanotubes. Toxicol In Vitro. 2014; 29(6):1275-82. DOI: 10.1016/j.tiv.2014.10.022. View

11.

Kinjo Y, Takatsuka S, Kitano N, Kawakubo S, Abe M, Ueno K . Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control. Front Immunol. 2018; 9:1266. PMC: 5997780. DOI: 10.3389/fimmu.2018.01266. View

12.

Barral D, Brenner M . CD1 antigen presentation: how it works. Nat Rev Immunol. 2007; 7(12):929-41. DOI: 10.1038/nri2191. View

13.

Holtzman M, Byers D, Alexander-Brett J, Wang X . The role of airway epithelial cells and innate immune cells in chronic respiratory disease. Nat Rev Immunol. 2014; 14(10):686-98. PMC: 4782595. DOI: 10.1038/nri3739. View

14.

Gonzalez R, Yang Y, Griffin C, Allen L, Tigue Z, Dobbs L . Freshly isolated rat alveolar type I cells, type II cells, and cultured type II cells have distinct molecular phenotypes. Am J Physiol Lung Cell Mol Physiol. 2004; 288(1):L179-89. DOI: 10.1152/ajplung.00272.2004. View

15.

Olszak T, Neves J, Dowds C, Baker K, Glickman J, Davidson N . Protective mucosal immunity mediated by epithelial CD1d and IL-10. Nature. 2014; 509(7501):497-502. PMC: 4132962. DOI: 10.1038/nature13150. View

16.

Layre E, Collmann A, Bastian M, Mariotti S, Czaplicki J, Prandi J . Mycolic acids constitute a scaffold for mycobacterial lipid antigens stimulating CD1-restricted T cells. Chem Biol. 2009; 16(1):82-92. DOI: 10.1016/j.chembiol.2008.11.008. View

17.

OGarra A, Redford P, McNab F, Bloom C, Wilkinson R, Berry M . The immune response in tuberculosis. Annu Rev Immunol. 2013; 31:475-527. DOI: 10.1146/annurev-immunol-032712-095939. View

18.

Messier E, Mason R, Kosmider B . Efficient and rapid isolation and purification of mouse alveolar type II epithelial cells. Exp Lung Res. 2012; 38(7):363-73. DOI: 10.3109/01902148.2012.713077. View

19.

Zeissig S, Dougan S, Barral D, Junker Y, Chen Z, Kaser A . Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function. J Clin Invest. 2010; 120(8):2889-99. PMC: 2912200. DOI: 10.1172/JCI42703. View

20.

Porcelli S, Modlin R . The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol. 1999; 17:297-329. DOI: 10.1146/annurev.immunol.17.1.297. View